Shanghai Runda Medical Technology Co Ltd
SSE:603108
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
|
Shanghai Runda Medical Technology Co Ltd
SSE:603108
|
9.9B CNY |
Loading...
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD |
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
190.5B USD |
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
150.8B USD |
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
79.2T KRW |
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
35.6B CHF |
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
292.3B CNY |
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
35.8B USD |
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.7B USD |
Loading...
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28.1B USD |
Loading...
|
|
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
163.2B HKD |
Loading...
|
Market Distribution
| Min | -409 046.1% |
| 30th Percentile | -1.4% |
| Median | 4.2% |
| 70th Percentile | 10.3% |
| Max | 876.4% |
Other Profitability Ratios
Shanghai Runda Medical Technology Co Ltd
Glance View
Shanghai Runda Medical Technology Co Ltd, nestled in the bustling heart of China's economic capital, stands as a quintessential example of a company thriving at the crossroads of innovation and healthcare. Established as a key player in medical diagnostics, Runda Medical focuses on the distribution and provision of high-quality medical devices and diagnostic solutions. Their business model revolves around integrating advanced technology with healthcare needs, enabling medical institutions to enhance their diagnostics capabilities through cutting-edge equipment and robust system support. The company holds a substantial portfolio of both proprietary and partnered products, allowing healthcare providers faster and more precise diagnostic insights. This is bolstered by a dependable supply chain and comprehensive after-sales service, ensuring that medical institutions can rely on consistent performance from their systems. Runda Medical's financial engine is powered predominantly by its distribution networks and strategic partnerships with leading medical technology firms worldwide. By leveraging these alliances, the company can offer a wide range of products that serve various segments of the medical industry, including hospitals, clinics, and laboratories. Revenue flows are primarily generated through the sale of medical devices such as automated analyzers, imaging systems, and diagnostic reagents — all designed to meet the growing demands for efficiency and accuracy in healthcare diagnosis. Moreover, their value proposition is further enhanced by the company's investments in customer education and training, ensuring that the end-users of their systems are not just purchasers but long-term partners in progress, thereby solidifying Runda Medical's reputation as a steadfast ally in China's healthcare landscape.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Shanghai Runda Medical Technology Co Ltd is 3.1%, which is below its 3-year median of 6.8%.
Over the last 3 years, Shanghai Runda Medical Technology Co Ltd’s Operating Margin has decreased from 9.7% to 3.1%. During this period, it reached a low of 3.1% on Sep 30, 2025 and a high of 10% on Mar 31, 2023.